Antiretroviral Drugs
Drug Classes, HIV Replication Targets, HAART, Resistance & Prophylaxis
Past RGUHS + DNB + MPMSU + MUHS + VNSGU · 32
RGUHSSep '25
RGUHSMay '25
DNBDec '25
RGUHSJun '24
RGUHSDec '23
RGUHSJul '23
DNBOct '23
VNSGUJun '23
RGUHSNov '22
RGUHSJul '21
MUHSWinter '21
VNSGUJun '21
RGUHSNov '20
RGUHSJun '20
RGUHSMay '18
RGUHSNov '17
MUHSSummer '17 Suppl
VNSGUMay '17
RGUHSJun '16
VNSGUApr '16
MPMSU2015
DNBDec '15
MUHSWinter '15
DNBDec '14
RGUHSMay '11
RGUHSMay '11
RGUHSMay '10
RGUHSMay '09
MPMSU2009
MPMSU2007
RGUHSSep '06
RGUHSSep '06
Introduction
- Antiretroviral (ARV) drugs are agents active against HIV, a lentivirus (retrovirus subfamily). They suppress replication and prolong life but do not cure — because the HIV genome integrates into host DNA, eradication is impossible with current agents.
- Goal of therapy — maximal, durable suppression of plasma HIV-RNA to undetectable (<20–50 copies/mL) with a rise in CD4 count; the deeper the suppression, the lower the risk of resistance. With early, adherent ART, life expectancy approaches that of an uninfected person.
- Treatment is lifelong, complex and adherence-critical; combination therapy (≥3 drugs from ≥2 classes) is mandatory — monotherapy is contraindicated.
- Two species — HIV-1 (global epidemic) and HIV-2 (West Africa, less virulent). Most ARVs cover both except NNRTIs and enfuvirtide, which are HIV-1-specific.
Continue reading
Antiretroviral Drugs
PharmaNotes Pro · LAQ
Sign in with your Google account. If you're already subscribed, the chapter unlocks immediately — otherwise, pick Monthly or Annual on the next step.